Found: 6
Select item for more details and to access through your institution.
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-53273-7
- By:
- Publication type:
- Article
Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2021, v. 204, n. 9, p. 1086, doi. 10.1164/rccm.202101-0117OC
- By:
- Publication type:
- Article
Examining nonadherence in the treatment of tuberculosis: The patterns that lead to failure.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 1965, doi. 10.1111/bcp.15515
- By:
- Publication type:
- Article
Proposed Linezolid Dosing Strategies to Minimize Adverse Events for Treatment of Extensively Drug-Resistant Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 10, p. 1736, doi. 10.1093/cid/ciab699
- By:
- Publication type:
- Article
Pharmacokinetic analysis across studies to drive knowledge‐integration: A tutorial on individual patient data meta‐analysis (IPDMA).
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 9, p. 1187, doi. 10.1002/psp4.13002
- By:
- Publication type:
- Article
Analysis of Dynamic Efficacy Endpoints of the Nix-TB Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 11, p. 1903, doi. 10.1093/cid/ciad051
- By:
- Publication type:
- Article